Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups

Diabetes and Metabolism

Volumn 37, Issue 3, 2011, Pages 252-258

  Yamada, T ^a   Fukatsu, M ^a   Suzuki, S ^b   Wada, T ^a   Joh, T ^b  

^a Okazaki City Medical Association   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Impaired fasting glucose; Multiple logistic regression analysis; Type 2 diabetes mellitus; Uric acid

Indexed keywords

GLUCOSE; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CIGARETTE SMOKING; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAMILY HISTORY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERURICEMIA; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICAL EXAMINATION; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; URIC ACID;

EID: 79958829087     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.10.009     Document Type: Article

References (41)

1. Kawamoto R., Tomita H., Oka Y., Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 2006, 45:605-614.
2. Tsouli S.G., Liberopoulos E.N., Mikhailidis D.P., Athyros V.G., Elisaf M.S. Elevated serum uric acid levels in metabolic syndrome: an active component or innocent bystander? Metabolism 2006, 55:1293-1301.
3. Nan H., Qiao Q., Dong Y., Gao W., Tang B., Qian R., et al. The prevalence of hyperuricemia in a population of the costal city of Qingdao. China. J Rhematol 2006, 33:1346-1350.
4. Chou P., Lin K.C., Lin H.Y., Tsai S.T. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol 2001, 28:571-576.
5. Yoo T.W., Sung K.C., Shin H.S., Kim B.J., Kim B.S., Kang J.H., et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005, 69:928-933.
6. Yamada T., Suzuki S., Fukatsu M., Wada T., Yoshida T., Joh T. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastro-Enterologica Belgica 2010, 73:12-17.
7. Li Y., Xu C., Yu C., Xu L., Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009, 50:1029-1034.
8. Inoue K., Matsumoto M., Akimoto K. Fasting plasma glucose and HbA1c as risk for type 2 diabetes. Diabet Med 2008, 25:1157-1163.
9. Ning F., Pang Z.C., Dong Y.H., Gao W.G., Nan H.R., Wang S.J., et al. Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao. China. Diabet Med 2009, 26:855-863.
10. Yamada T., Fukatsu M., Suzuki S., Wada T., Yoshida T., Joh T. Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup. J Gastroenterol Hepatol 2010, 25:352-356.
11. Yates T., Khunti K., Bull F., Gorely T., Davies M.J. The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia 2007, 50:1116-1126.
12. Kodama S., Saito K., Yachi Y., Asumi M., Sugawara A., Totsuka K., et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009, 32:1737-1742.
13. Nakanishi N., Okamoto M., Yoshida H., Matsuo Y., Suzuki K., Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
14. Choi H.K., De Vera M.A., Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 2008, 47:1567-1570.
15. Chien K.L., Chen M.F., Hsu H.C., Chang W.T., Su T.C., Lee Y.T., et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008, 54:310-316.
16. Kramer C.K., von Mühlen D., Jassal S.K., Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care 2009, 32:1272-1273.
17. Li Y., Stamler J., Xiao Z., Folsom A., Tao S., Zhang H. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA Collaborative Study in Cardiovascular and Cardiopulmonary Epidemiology. Int J Epidemiol 1997, 26:288-296.
18. Rathmann W., Strassburger K., Heier M., Holle R., Thorand B., Giani G., et al. Incidence of Type2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med 2009, 26:1212-1219.
19. Dehghan A., van Hoek M., Sijbrands E.J., Hofman A., Witteman J.C. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 312:361-362.
20. Meisinger C., Thorand B., Schneider A., Stieber J., Döring A., Löwel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med 2002, 162:82-89.
21. Nan H., Qiao Q., Söderberg S., Pitkäniemi J., Zimmet P., Shaw J., et al. Serum uric acid and incident diabetes in Mauritian Indian and Creole populations. Diabetes Res Clin Pract 2008, 80:321-327.
22. Lin K.C., Tsai S.T., Lin H.Y., Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol 2004, 31:1159-1165.
23. Taniguchi Y., Hayashi T., Tamura K., Endo G., Fujii S., Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: Osaka Health Survey. J Hypertens 2001, 19:1209-1215.
24. Oda E., Kawai R., Sukumaran V., Watanabe K. Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 2009, 48:1785-1791.
25. de Vegt F., Dekker J.M., Jager A., Hienkens E., Kostense P.J., Stehouwer C.D., et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2001, 285:2109-2113.
26. Moriuchi T., Oka R., Yagi K., Miyamoto S., Nomura H., Yamagishi M., et al. Diabetes progression from " high-normal" glucose in school teachers. J Intern Med 2010, 49:1271-1276.
27. Unwin N., Shaw J., Zimmet P., Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002, 19:708-723.
28. Moebus S., Stang A., Möhlenkamp S., Dragano N., Schmermund A., Slomiany U., et al. Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of Heinz Nixdorf Recall Study. Diabetologia 2009, 52:81-89.
29. Chen K.T., Chen C.J., Gregg E.W., Imperatore G., Narayan K.M. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 2003, 60:177-182.
30. Osawa H., Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996, 24:25-29.
31. Liberopoulos E.N., Miltiadous G.A., Elisaf M.S. Alcohol intake, serum uric acid concentrations, and risk of gout. Lancet 2004, 364:246-247.
32. Klein B.E., Klein R., Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002, 25:1790-1794.
33. Joyner J.M., Hutley L.J., Cameron D.P. Glucocorticoid receptors in human preadipocytes: regional and gender differences. J Endocrinol 2000, 166:145-152.
34. Matsuura F., Yamashita S., Nakamura T., Nishida M., Nozaki S., Funahashi T., et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998, 47:929-933.
35. Quinones Galavan A., Natali A., Baldi S., Frascerra S., Sanna G., Ciociaro D., et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995, 268:E1-E5.
36. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
37. Fox I.H. Metabolic basis for disorders of purine nucleotide degradation. Metabolism 1981, 30:616-634.
38. Butler R., Morris A.D., Belch J.J., Hill A., Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetes with mild hypertension. Hypertension 2000, 35:746-751.
39. Baumann A., Stieber J., Löwel H. Nonparticipation as a factor influencing the value of follow-up studies. Gesundheitswesen 1997, 59:19-25.
40. James S.A., Jamjoum L., Raghunathan T.E., Strogatz D.S., Furth E.D., Khazanie P.G. Physical activity and NIDDM in African-Americans. The Pitt County Study. Diabetes Care 1998, 21:555-562.
41. Choi H.K. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010, 22:165-172.